Molecular and functional changes of pulmonary surfactant in response to hyperoxia

Pediatric Pulmonology

Volumn 41, Issue 11, 2006, Pages 1025-1039

  Dombrowsky, Heike ^a   Tschernig, Thomas ^b   Vieten, Gertrud ^b   Rau, Gunnar A ^b   Ohler, Florian ^c   Acevedo, Christa ^b   Behrens, Clemens ^b   Poets, Christian F ^c   Von Der Hardt, Horst ^b   Bernhard, Wolfgang ^c,d  

^a RESEARCH CENTER BORSTEL   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Children's Hospital   (Germany)

Author keywords

Arachidonic acid; Hyperoxic lung injury; Mass spectrometry; Phosphatidylcholine molecular species; Phosphatidylglycerol molecular species; Phosphatidylinositol molecular species; Phospholipid metabolism; Surfactant function

Indexed keywords

ARACHIDONIC ACID; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPID; LUNG SURFACTANT; MYRISTOYLPALMITOYLLECITHIN; PALMITOYLPALMITOLEOYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HYPEROXIA; INFLAMMATORY DISEASE; LONG TERM EXPOSURE; LUNG ALVEOLUS; LUNG ALVEOLUS CELL TYPE 2; LUNG EMBOLISM; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 33750971438     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20443     Document Type: Article

References (41)

1. Crapo JD, Barry BE, Foscue HA, Shelburne JS. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980;122:123-145.
2. Del Riccio V, Tuyl MV, Post M. Apoptosis in lung development and neonatal lung injury. Pediatr Res 2004;55:183-189.
3. Ray P, Devaux Y, Stolz DB, Yarlagadda M, Watkins SC, Lu Y, Chen L, Yang XF, Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci USA 2003;100:6098-6103.
4. Sugahara K, Iyama K, Sano K, Kuroki Y, Akino T, Matsumoto M. Overexpression of surfactant protein SP-A, SP-B and SP-C mRNA in rat lungs with lipopolysaccharide induced injury. Lab Invest 1996;74:209-220.
5. Bernhard W, Hoffmann S, Dombrowsky H, Rau GA, Kamlage A, Kappler M. Haitsma JJ, Freihorst J, von der Hardt H, Poets CF. Phosphatidylcholine molecular species in lung surfactant-composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol 2001;25:725-731.
6. Chao W. Spragg RG, Smith RM. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils: attenuation of p47phox and p67phox membrane translocation as the mechanism. J Clin Invest 1995;96:2654-2660.
7. Smith RM, Spragg R, Connor J. Surfactant phospholipids inhibit neutrophil NADPH oxidase activity in a cell free system. Am J Respir Crit Care Med 1999;159:A894, (Abstract).
8. Rau GA, Vieten G, Haitsma JJ, Freihorst J, Poets CF, Ure BM, Bernhard W. Surfactant in newborn compared to adolescent pigs: adaptation to neonatal respiration. Am J Respir Cell Mol Biol 2004;30:694-701.
9. 2. J Appl Physiol 1987;62:2230-2236.
10. Yue G, Matalon S. Mechanisms and sequelae of increased alveolar fluid clearance in hyperoxic rats. Am J Physiol Lung Cell Mol Physiol 1997;272:L407-L412.
11. Fehrenbach H, Brasch F, Uhlig S, Weisser M, Stamme C, Wendel A, Richter J. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin. Am J Respir Crit Care Med 1998;157:1630-1639.
12. Holm BA, Wang Z, Notter RH. Multiple mechanisms of lung surfactant inhibition. Pediatr Res 1999;46:85-93.
13. Palazzo RM, Wangensteen OD, Niewöhner DE. Time course of functional repair of the alveolar epithelium after hyperoxic injury. J Appl Physiol 1992;73:1881-1887.
14. Royston BD, Webster NR, Nunn JF. Time course of changes in lung permeability and edema in the rat exposed to 100% oxygen. J Appl Physiol 1990;69:1532-1537.
15. Zimmerman JJ, Lewandoski JR. Activated polymorphonuclear leukocytes inhibit phosphatidylcholine synthesis in cultured type II alveolar cells. Pediatr Pulmonol 1991;10:164-171.
16. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474-475.
17. Westermann J, Ronneberg S, Fritz FJ, Pabst R. Proliferation of lymphocyte subsets in the adult rat: a comparison of different lymphoid organs. Eur J Immunol 1989;19:1087-1093.
18. Westermann J, Persin S, Matyas J, van der Meide P, Pabst R. IFN-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph. J Immunol 1993;150:3843-3852.
19. Bernhard W, Gebert A, Vieten G, Rau GA, Hohlfeld JM, Postle AD, Freihorst J. Pulmonary surfactant in birds: coping with surface tension in a tubular lung. Am J Physiol Regul Integrat Comp Physiol 2001;281:R327-R337.
20. Shelley SA, Paciga JE, Balis JU. Purification of surfactant from lung washings and washings contaminated with blood constituents. Lipids 1977;12:505-510.
21. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977;43:198-203.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
24. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1956;226:497-509.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
26. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
27. Postle AD, Mander A, Reid KBM, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 1999;20:90-98.
28. tm1HGU/TM1HGU mice compared to MF-1 mice. Exp Lung Res 2001;27:349-366.
29. Rau GA, Dombrowsky H, Gebert A, Thole HH, von der Hardt H, Freihorst J, Bernhard W. Phosphatidylcholine metabolism of rat trachea in relation to lung parenchyma and surfactant. J Appl Physiol 2003;95:1145-1152.
30. Yu S-H, Possmayer F. Role of bovine pulmonary surfactant-associated proteins in the surface-active properties of phospholipid mixtures. Biochim Biophys Acta 1990;1046:233-241.
31. Bernhard W, Postle AD, Rau GA, Freihorst J. 2001. Pulmonary and gastric surfactants. A comparison of the effect of surface requirements on function and phospholipid composition. Comp Biochem Physiol Part A 129:173-182.
32. D'Angio CT, Finkelstein JN, Lomonaco MB, Paxhia A, Wright SA, Baggs RB, Notter RH, Ryan RM. Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. Am J Physiol Lung Cell Mol Physiol 1997;272: L720-L730.
33. Nogee LM, Wispe JR, Clark JC, Weaver TE, Whitsett JA. Increased expression of pulmonary surfactant proteins in oxygen-exposed rats. Am J Respir Cell Mol Biol 1991;4:102-107.
34. Palazzo RM, Wangensteen OD, Niewöhner DE. Time course of functional repair of the alveolar epithelium after hyperoxic injury. J Appl Physiol 1992;73:1881-1887.
35. Sugahara K, Iyama K, Sano K, Kuroki Y, Akino T, Matsumoto M. Overexpression of surfactant protein SP-A, SP-B and SP-C mRNA in rat lungs with lipopolysaccharide induced injury. Lab Invest 1996;74:209-220.
36. Piedbeouf B, Frenette J, Petrov P, Welty SE, Kazzaz JA, Horowitz S. In vivo expression of intercellular adhesion molecule 1 in type II pneumocytes during hyperoxia. Am J Respir Cell Mol Biol 1996;15:71-77.
37. Gross NJ, Smith DM. Impaired surfactant phospholipid metabolism in hyperoxic mouse lungs. J Appl Physiol 1981;51:1198-1203.
38. 3H in alveolar type II pneumocytes in relation to surfactant synthesis: a quantitative autoradiographic study. Anat Rec 1972;174:289-310.
39. Bernal AL, Phizackerley PJ. Fetal surfactant as a source of arachidonate in human amniotic fluid. Prostagland Other Lip Mediat 2000;60:59-70.
40. Baybutt RC, Smith JE, Gillespie MN, Newcomb TG, Yeh YY. Arachidonic acid and eicosapentaenoic acid stimulate type II pneumocyte surfactant secretion. Lipids 1994;29:535-539.
41. Holtzman RB, Zemaitis J, Adler L, Smith LJ, Hunt CE, Hageman JR. Role of eicosanoids in relative oxygen tolerance of newborn rabbits. Prostaglandins 1989;37:481-491.